Neutra Corp.

NTRR

US64129C3034

Pharmaceuticals

Delayed OTC Markets Other stock markets 15:51:33 17/05/2024 BST			5-day change	1st Jan Change
0.0003 ^USD	-25.00%		0.00%	0.00%

2023	Neutra Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023	CI
2023	Neutra Corp. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2023	CI

Neutra Corp. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2022

September 14, 2022 at 08:49 pm

Neutra Corp. reported earnings results for the second quarter and six months ended July 31, 2022. For the second quarter, the company reported sales was USD 0.029032 million compared to USD 0.015807 million a year ago. Net loss was USD 0.097426 million compared to USD 0.140883 million a year ago.
For the six months, sales was USD 0.038694 million compared to USD 0.02736 million a year ago. Net loss was USD 0.204622 million compared to USD 0.278199 million a year ago.

Latest news about Neutra Corp.

Neutra Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023	12-15	CI
Neutra Corp. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2023	14/09/23	CI
Neutra Corp. Reports Earnings Results for the First Quarter Ended April 30, 2023	22/06/23	CI
Neutra Corp. Reports Earnings Results for the Full Year Ended January 31, 2023	09/06/23	CI
Neutra Corp. Auditor Raises 'Going Concern' Doubt	08/06/23	CI
Neutra Corp. executed a binding letter of intent to acquire Mercury Clinical Research, Inc.	29/01/23	CI
Neutra Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2022	15/12/22	CI
Neutra Corp. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2022	14/09/22	CI
Neutra Corp. Reports Earnings Results for the First Quarter Ended April 30, 2022	21/06/22	CI
Neutra Corp. Reports Earnings Results for the Full Year Ended January 31, 2022	10/05/22	CI
Neutra Corp. Auditor Raises 'Going Concern' Doubt	09/05/22	CI
Neutra Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2021	10/12/21	CI
Neutra Corp. Reports Earnings Results for the Second Quarter Ended July 31, 2021	14/09/21	CI
Neutra Corp. acquired Deity Wellness.	22/06/21	CI
Neutra Corp. Reports Earnings Results for the First Quarter Ended April 30, 2021	21/06/21	CI
Neutra Corp. Reports Earnings Results for the Third Quarter Ended October 31, 2020	21/12/20	CI
Neutra Corp. Reports Earnings Results for the Second Quarter Ended July 31, 2020	14/09/20	CI
Neutra Corp. Reports Earnings Results for the First Quarter Ended April 30, 2020	14/07/20	CI
Neutra Corp.'s VIVIS Introduces three New Products into the CBD Marketplace	02/07/20	CI
Neutra Corp. announced that it has received funding	31/12/19	CI
Neutra Corp. Reports Earnings Results for the Third Quarter Ended October 31, 2019	23/12/19	CI
Neutra Corp. Reports Earnings Results for the Second Quarter Ended July 31, 2019	23/09/19	CI
Neutra Corp. completed the acquisition of Vivis Corporation from Sydney Jim and others.	09/09/19	CI
Neutra Corp. entered into letter of intent to acquire Vivis Corporation from Sydney Jim and others for $0.04 million.	25/07/19	CI
Neutra Corp. Reports Earnings Results for the First Quarter Ended April 30, 2019	14/06/19	CI

Chart Neutra Corp.

Duration

Period

More charts

Company Profile

Neutra Corp. is an early-stage research and development company. The Company is engaged in marketing and participating in the nutraceutical space by bringing products derived from all natural and organic origins. The Company plans to research and bring new technology to the Nutraceutical space. The Company is primarily focused on participating in the medical cannabis market, which is a nutraceutical sub-market. It intends to entrust the manufacturing to a nutraceutical contractor to private label all of its products and to sell them under its brand. It primarily sells hemp-derived products, including products containing delta-8-THC and other cannabinoids. Its subsidiaries include Diamond Anvil Designs, LLC, Deity Corporation and Vivis Corporation.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
NEUTRA CORP.	0.00%	1.17M
ELI LILLY AND COMPANY	+32.01%	694B
NOVO NORDISK A/S	+29.39%	593B
JOHNSON & JOHNSON	-1.60%	371B
MERCK & CO., INC.	+19.90%	331B
ABBVIE INC.	+6.84%	290B
ASTRAZENECA PLC	+14.25%	239B
ROCHE HOLDING AG	-3.03%	209B
NOVARTIS AG	+10.02%	209B
AMGEN INC.	+7.99%	169B